PYC 4.00% 12.0¢ pyc therapeutics limited

Ann: Polycystic Kidney Disease Program Presentation, page-4

  1. 205 Posts.
    lightbulb Created with Sketch. 1748
    Here is my recording of the PKD Presentation today:

    "PYC's PKD Polycystic Kidney Disease Drug PYC-003 Presentation 12PM 17 Nov 2023"

    PYC Therapeutics CEO Dr. Rohan Hockings hosted a video presentation on 17 November 2023 at 12pm AEST to provide an update on their 4th drug in the pipeline for PKD Polycystic Kidney Disease. He highlighted the high-velocity path to market with the potential for approval after a Phase 2 clinical trial, and an estimated FDA approval / commercialisation in 2027.


    The presentation was in an odd format beyond 1920x1080. Therefore a bit of effort was required to rescale the video to fit within the FHD screen.

    If you appreciate my effort, please hit the Like button in Youtube and the Good Analysis buttons below biggrin.png
    Last edited by Medicine Man: 18/11/23
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
(20min delay)
Last
12.0¢
Change
-0.005(4.00%)
Mkt cap ! $559.9M
Open High Low Value Volume
12.3¢ 12.5¢ 11.8¢ $108.1K 901.2K

Buyers (Bids)

No. Vol. Price($)
9 1170950 11.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 31 1
View Market Depth
Last trade - 16.10pm 27/06/2024 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.